Cyclacel Pharmaceuticals, Inc. (CYCC) Posts Q4 Loss of 19c/Share

March 25, 2014 4:05 PM

Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) reported Q4 EPS of ($0.19) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found